Black women in the United States have higher breast cancer mortality than white women with the same disease. Both access to care and tumor biology play a role in these disparities. The Carolina Breast Cancer Study is a patient cohort that over-sampled black
women and young women to elucidate causes of mortality disparities. This talk will describe the molecular work being performed on the CBCS and will illustrate that integration of biology and access to care provide important insights on key intervention strategies.